BONINI, Sergio
 Distribuzione geografica
Continente #
EU - Europa 10.744
NA - Nord America 5.744
AS - Asia 4.344
SA - Sud America 917
AF - Africa 65
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 6
Totale 21.831
Nazione #
RU - Federazione Russa 6.498
US - Stati Uniti d'America 5.687
SG - Singapore 1.796
IE - Irlanda 1.326
UA - Ucraina 987
HK - Hong Kong 825
CN - Cina 804
BR - Brasile 768
GB - Regno Unito 654
DE - Germania 411
VN - Vietnam 334
FI - Finlandia 258
SE - Svezia 191
IN - India 170
TR - Turchia 158
GR - Grecia 152
IT - Italia 126
KR - Corea 54
AR - Argentina 48
JP - Giappone 48
FR - Francia 31
ID - Indonesia 31
BD - Bangladesh 29
EC - Ecuador 26
BE - Belgio 25
CA - Canada 20
MX - Messico 20
CO - Colombia 18
AT - Austria 17
IQ - Iraq 17
VE - Venezuela 15
NL - Olanda 14
PK - Pakistan 14
PY - Paraguay 13
ZA - Sudafrica 13
TN - Tunisia 11
DZ - Algeria 10
JO - Giordania 10
UY - Uruguay 10
CL - Cile 8
PL - Polonia 8
SA - Arabia Saudita 8
ES - Italia 7
EU - Europa 7
KE - Kenya 7
PE - Perù 7
LT - Lituania 6
CH - Svizzera 5
CZ - Repubblica Ceca 5
EG - Egitto 5
IL - Israele 5
JM - Giamaica 5
MA - Marocco 5
UZ - Uzbekistan 5
BO - Bolivia 4
LB - Libano 4
PT - Portogallo 4
TH - Thailandia 4
AE - Emirati Arabi Uniti 3
AM - Armenia 3
AP - ???statistics.table.value.countryCode.AP??? 3
AU - Australia 3
BY - Bielorussia 3
GG - Guernsey 3
IR - Iran 3
NZ - Nuova Zelanda 3
PH - Filippine 3
RS - Serbia 3
AL - Albania 2
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GA - Gabon 2
HN - Honduras 2
KZ - Kazakistan 2
LY - Libia 2
NP - Nepal 2
PS - Palestinian Territory 2
RO - Romania 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BJ - Benin 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
GE - Georgia 1
GM - Gambi 1
HU - Ungheria 1
LV - Lettonia 1
MY - Malesia 1
NA - Namibia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
Totale 21.824
Città #
Moscow 2.290
Jacksonville 1.465
Dublin 1.322
Hong Kong 824
Santa Clara 571
Chandler 552
Singapore 502
San Jose 349
Ashburn 248
Princeton 245
Medford 234
San Mateo 167
Boardman 161
Wilmington 115
Ho Chi Minh City 107
Bengaluru 104
Ann Arbor 89
Hanoi 85
Hefei 82
The Dalles 74
Dallas 67
Woodbridge 66
Beijing 63
Roxbury 56
Cambridge 54
São Paulo 53
New York 42
Des Moines 38
Seoul 37
Rio de Janeiro 27
Los Angeles 20
Rome 20
Brasília 19
Brussels 18
Redwood City 18
Haiphong 17
Mountain View 17
Nanjing 17
Belo Horizonte 16
Da Nang 16
Pune 16
Düsseldorf 15
Houston 14
Nuremberg 14
Jinan 13
Campinas 12
Curitiba 12
London 12
Shanghai 12
Dhaka 11
Kunming 11
Norwalk 11
Quito 11
Atlanta 10
Hangzhou 10
Bogotá 9
Munich 9
Salvador 9
Tianjin 9
Vienna 9
Caxias do Sul 8
Frankfurt am Main 8
Lappeenranta 8
Montevideo 8
Fairfield 7
Guangzhou 7
Nova Iguaçu 7
Tokyo 7
Auburn Hills 6
Biên Hòa 6
Brooklyn 6
Fortaleza 6
Johannesburg 6
Manaus 6
Milan 6
Montes Claros 6
Nairobi 6
Orem 6
Santo André 6
Seattle 6
Amman 5
Asunción 5
Baghdad 5
Bauru 5
Betim 5
Bremen 5
Bắc Giang 5
Can Tho 5
Changsha 5
Città di Castello 5
Contagem 5
Goiânia 5
Haikou 5
Helsinki 5
Hải Dương 5
Jakarta 5
Jinju 5
Joinville 5
Nanchang 5
New Delhi 5
Totale 10.728
Nome #
Global Allergy and Asthma European Network: Grading of Recommendations Assessment, Development and Evaluation Working Group: Allewrgic Rhinitis and its Impact on Asthma (ARIA) Guidelines: 2010 revision 282
Allergic Rhinitis and its Impact on Asthma (ARIA): In collaboration with the World Health Organization 172
Epidemiology of allergic occupational diseases induced by Tetranychus urticae in greenhouse and open-field farmers living in a temperate climate area 157
A case-control study of the relation between plasma selenium and asthma in European populations: a GAL2EN project 144
A multicentric study on sensitivity and specificity of a new in vitro test for measurement of IgE antibodies 135
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen) 134
Adult SURF Study Group. A survey of clinical features of allergic rhinitis in adults 133
GA2LEN (GLOBAL ALLERGY AND ASTHMA EUROPEAN NETWORK) ADDRESSES THE ALLERGY AND ASTHMA 'EPIDEMIC' 130
Allergenic pollen and pollen allergy in Europe 129
Uso del Fattore di crescita nervoso (NGF)per l'espansione in vitro di cellule staminali del cordone ombelicale 129
[New methods in allergology] 123
Allergen immunotherapy on the way to product-based evaluation - a WAO statement 123
Allergen extracts. Standardization of preparations for bronchial provocation tests. A position paper. (EAACI Sub-committee on Bronchial Provocation Tests) 122
AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation 122
GA(2)LEN (Global Allergy and Asthma European Network): European network of excellence for asthma and allergic diseases 119
Uso dei probiotici nella prevenzione e nel trattamento delle congiuntiviti allergiche 118
GA(2)LEN SKIN TEST STUDY II: CLINICAL RELEVANCE OF INHALANT ALLERGEN SENSITIZATIONS IN EUROPE 115
Prophylactic management of children at risk for recurrent upper respiratory infections: the Preventia I Study. 115
Allergic conjunctivitis 114
[Autoimmunity and lymphoproliferative diseases (proceedings)] 114
The genetics of atopy 113
[Phadiatop, a new in vitro method in the diagnosis and prevention of respiratory allergic diseases] 113
Allergic chronic inflammation of the ocular surface in vernal keratoconjunctivitis 112
POLLENOSIS 2000. GLOBAL APPROACH 112
Microbial products in allergy prevention and therapy 111
Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma 111
Allergic bronchial airway inflammation in Nerve Growth Factor (NGF) – derived rats: evidence suggesting a neuroimmunomodulatory role of NGF 111
Allergen dose response and late symptoms in a human model of ocular allergy 110
GA(2)LEN SKIN TEST STUDY I: GA(2)LEN HARMONIZATION OF SKIN PRICK TESTING: NOVEL SENSITIZATION PATTERNS FOR INHALANT ALLERGENS IN EUROPE 109
Lymphocytotoxic HLA antibodies and HB infection in transfused hemodialysis patients waiting for kidney transplantation 109
Immunological aspects of chronic uremia 109
Allergic Conjunctivitis 109
Standard skin prick testing and sensitization to inhalant allergens across Europe – a survey from the GA2LEN network 108
T-helper 17 lymphocytes in ocular cicatricial pemphigoid 108
The eosinophil and the eye 107
EXERCISE-INDUCED ASTHMA, RESPIRATORY AND ALLERGIC DISORDERS IN ELITE ATHLETES: EPIDEMIOLOGY, MECHANISMS AND DIAGNOSIS: PART I OF THE REPORT FROM THE JOINT TASK FORCE OF THE EUROPEAN RESPIRATORY SOCIETY (ERS) AND THE EUROPEAN ACADEMY OF ALLERGY AND CLINICAL IMMUNOLOGY (EAACI) IN COOPERATION WITH GA2LEN 106
Rhinitis and asthma in athletes: an ARIA document in collaboration with GA2LEN 106
Effects of topical pre-treatment with dexamethasone on the immediate and late phases of topically induced ocular anaphylaxis in the rat 106
Integrated care pathways for airway diseases (AIRWAYS-ICPs). 105
Which population level environmental factors are associated with asthma, rhinoconjunctivitis and eczema? Review of the ecological analyses of ISAAC Phase One 105
Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper. 105
Nerve growth factor (NGF): an important molecule for trophism and healing of the ocular surface 105
Reply to the letter of Dr. Feinberg in J Allergy Clin Immunol 1990; 85:141-2 105
100 years of immunotherapy: the Monaco charter. under the high patronage of His Serene Highness Prince Albert II of Monaco. 105
The additional values of microarray allergen assay in the management of polysensitized patients with respiratory allergy 104
Topical treatment with nerve growth factor for corneal neurotrophic ulcers 104
A survey of clinical features of allergic rhinitis in adults. 104
Reply 103
Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update 103
Evidence of non reproducibility. Human basophil histamine release is not triggered by very diluted anti-IgE. Letter 103
Barriers to new drug development in respiratory disease 103
The CONSORT statement checklist in allergen-specific immunotherapy: a GA2LEN paper 102
Increased plasma levels of nerve growth factor in vernal keratoconjunctivitis 102
Allergic Eye Disorders 102
Efficacy of lodoxamide eye drops on mast cells and eosinophils after allergen challenge in allergic conjunctivitis 101
Immunological profile of peripheral blood eosinophils in acute graft-vs-host disease 101
Allergic conjunctivitis: the forgotten disease 101
International consensus on allergy immunotherapy 101
Copyright. AQUE. Allergy Questionnaire for Exercisers 101
Tear levels of neuropeptides increase after specific allergen challenge in allergic conjunctivitis. 100
GA2LEN SKIN TEST STUDY III: MINIMUM BATTERY OF TEST INHALENT ALLERGENS NEEDED IN EPIDEMIOLOGICAL STUDIES IN PATIENTS 100
CLOSE CORRELATION BETWEEN ANXIETY; DEPRESSION; AND ASTHMA CONTROL, 100
Epidemiology of asthma, allergy and bronchial hyperresponsiveness in sports 100
Airway inflammation in the elite athlete and type of sport 100
Epidemiology of rhinitis and conjunctivitis in athletes. 99
Nerve Growth Factor effect on human primary fibroblastic-keratocytes: possible mechanism during corneal healing 99
Increased serum levels of eosinophil cationic protein and eosinophil-derived neurotoxin (protein X) in vernal keratoconjunctivitis 99
Primer di Allerghologia e Immunologia Clinica 99
Severe Chronic Allergic (and Related) Diseases: A Uniform Approach - A MeDALL - GA(2)LEN - ARIA Position Paper. 98
Nerve growth factor promotes corneal healing: structural, biochemical, and molecular analyses of rat and human corneas 98
Nerve Growth Factor has a modulatory role on human primary fibroblast coltures derived from vernal keratoconjunctivitis-affected conjunctiva 98
WHO Intiative. Allergic Rhinitis and its Impact on Asthma (ARIA) 98
Studies on the relationship between the level of specific IgE antibodies and the clinical expression of allergy: I. Definition of levels distinguishing patients with symptomatic from patients with asymptomatic allergy to common aeroallergens 98
Desloratadina: a new approach in the treatment of allergy as a systemic disease - pharmacology and clinical overview 98
Weight loss interventions in asthma: EAACI evidence-based clinical practice guideline (part I). 97
Pooling birth cohorts in allergy and asthma: European Union-funded initiatives - a MeDALL, CHICOS, ENRIECO, and GA²LEN joint paper 97
Low- versus high-baseline epinephrine output shapes opposite innate cytokine profiles: presence of Lewis- and Fischer-like neurohormonal immune phenotypes in humans? 97
Tear tryptase levels and allergic conjunctivitis 97
Flow cytometric evaluation of activated eosinophils in graft versus host disease and hypereosinophilic conditions 97
Dampness in buildings as a risk factor for health effects, EUROEXPO: a multidisciplinary review of the literature (1998-2000) on dampness and mite exposure in buildings and health effects. 96
Effects of Salmeterol on Skeletal Muscle Cells: Metabolic and Pro-Apoptotic Features. 96
Parietaria pollinosis: a review 96
Desloratadine: a new approach in the treatment of allergy as a systematic disease--pharmacology and clinical overview. Introduction 95
Serum levels of eosinophil cationic protein in allergic diseases and natural allergen exposure 95
Asthma and dietary intake: An overview of systematic reviews 95
Intestinal permeability in patients with adverse reactions to food 94
Practical approach to diagnosis and treatment of ocular allergy: a 1-year systematic review 94
Conjunctival fibroblasts enhance the survival and functional activity of peripheral blood eosinophils in vitro 94
Global Approach to the atopic Patient 94
First-in-human clinical trials - What we can learn from tragic failures 94
Non specific provocation of target organs in allergic diseases 93
Exercise-induced hypersensitivity syndromes in recreational and competitive athletes: a PRACTALL consensus report (what the general practitioner should know about sports and allergy) 93
Predictive value of allergy and pulmonary function tests for the diagnosis of asthma in elite athletes. 93
Immunotherapy of bronchial asthma 93
Building bridges for innovation in ageing: Synergies between Action Groups of the EIP on AHA 93
The relation between paracetamol use and asthma: a GA2LEN European case-control study 92
EAACI provocation tests with allergens. Report prepared by the European Academy of Allergology and Clinical Immunology Subcommittee on provocation tests with allergens 92
The pro-fibrogenic effect of nerve growth factor on conjunctival fibroblasts is mediated by transforming growth factor-beta 92
Markers of eosinophilic inflammation in allergic diseases 91
Conjunctival expression of thymosin-beta4 in vernal conjunctivitis 91
Totale 10.800
Categoria #
all - tutte 80.575
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.575


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202135 0 0 0 0 0 0 0 0 0 0 0 35
2021/20221.233 173 1 2 14 492 3 20 38 46 4 94 346
2022/20232.186 251 3 8 169 190 179 1 146 1.151 12 43 33
2023/2024912 72 23 31 131 374 37 4 30 13 9 40 148
2024/20252.877 13 20 27 62 367 258 512 277 352 641 214 134
2025/202610.310 374 342 572 659 801 6.157 497 145 466 176 78 43
Totale 21.909